Volatility in Fannie Mae and Freddie Mac Brings Traders to the Front Lines - Top Small Cap Trades Ahead of the Open: Fannie Mae, AMR Corp, Goff Corp, Titan Pharmaceuticals, Research in Motion

LONDON, March 22, 2013 /PRNewswire/ --

Shares in Fannie Mae and Freddie Mac experienced volatility for the first time yesterday in what was a big swing day for traders in the stocks.  Fannie Mae started off the morning by pushing straight to $1.50, and as we predicted it looked like the stock would move higher, it represented 500% gains in 1 week at that point.  Not surprisingly Fannie Mae pulled back to close at 0.80 cents on the day making this the heaviest traded stock in the over the counter market by some distance.  This story is bound to play out over the next week and chances are there will be many more chances to play this stock, bear in mind AMR Corporation pulled back to $1.00 before trading to $4.35.

AMR Corp is another example of a stock people had given up hope on and we have been covering for 2 months now.  During that time shares of AMR Corp have risen as much as 700% from top to bottom and it just goes to show you that recently with names like AMR Corp, Eastman Kodak, Fannie Mae, and Freddie Mac that there are plenty of profits to made by trading the OTC market if you are a prudent investor, or you're a member of http://www.clubpennystock.com.  Shares of AMR Corp rose a further 3% in trading yesterday to close at $4.38.

Goff Corp was indicating a higher open on Wall Street along with the futures today after the stock traded substantial volume in Thursday's trading session and moved lower only slightly after a solid 3 day run. Goff Corp appointed a new director late last week and the shares after receiving much attention climbed over 100% initially to close at 0.28 cents.  Intra-day we have seen shares of Goff Corporation trade as high as 0.35 cents, the stock closed yesterday at 0.33 cents right at a new high.

Shares of Research In Motion (NASDAQ: BBRY) is a large cap stock that we are featuring as an extra trading play.  The shares have been seeing plenty of trading action ahead of the launch of the new Z10 phone which there is much anticipation.  The stock is trading towards a new high and with the volume in yesterday's trading looks like the stock will trade higher.  The company is releasing its much anticipated new smart phone today in AT&T stores nationwide.

Titan Pharmaceuticals traded heavy volume in Thursday's session but is struggling to trade higher after its recent big slide in the price of its shares.  To close going into todays open Titan Pharmaceuticals traded over $8 million on the day and was lower by 2.3% on the trading day.

If you are looking to know what's going on with these companies on the OTC and in addition receive weekly picks on stocks that we feature, simply sign up at our website for free.

http://www.clubpennystock.com

Regardless of what's going on in the mainstream we will always keep you updated and look to be value added. We hope you have enjoyed our coverage; we will be back to you tomorrow with our daily look at the small cap markets.

We track the volume and keep in touch with any increasing trends to the upside or downside.  We also cover the top stocks on the OTCQB, OTCQX, and the Pink Sheet markets.

Disclosure: Clubpennystocks is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Clubpennystocks is a wholly owned entity of a financial public relations firm.  We have not been compensated by any of the companies listed in this news release.

Contact: Email: info@clubpennystocks.com / Tel: +1-561-417-7154


 

SOURCE Clubpennystocks.com




Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.